Unlock the power of C2 and invest in your health today
Pencek R, Blickensderfer A, Li Y, Brunell SC, Anderson PW
Novo Nordisk, maker of the glucagon-like peptide-1 (GLP-1) agonist medication semaglutide (Wegovy), recently received accelerated approval from the U.S
We carried out a 20-week study with a total of 900 hens to assess the effects of four dietary inclusion levels of AcM on nutrient digestibility (i.e., nitrogen retention, dry matter digestibility and apparent metabolizable energy) and on the caecal microbiota and microbiome
Aprobado en Estados Unidos desde 2017, este frmaco ha ganado popularidad n por el respaldo de figuras pblicas como Elon Musk, CEO de Tesla, quien ha compartido su experiencia en redes sociales